NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 48 filers reported holding NUVALENT INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $98,108,346 | +9.8% | 2,134,182 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $89,335,458 | +65.4% | 2,118,460 | +2.3% | 0.00% | +100.0% |
| Q1 2023 | $54,012,718 | -9.9% | 2,070,246 | +2.9% | 0.00% | -50.0% |
| Q4 2022 | $59,926,531 | +114.0% | 2,012,308 | +39.7% | 0.00% | +100.0% |
| Q3 2022 | $28,007,000 | +63.9% | 1,440,693 | +14.3% | 0.00% | – |
| Q2 2022 | $17,088,000 | -24.9% | 1,260,165 | -23.0% | 0.00% | -100.0% |
| Q1 2022 | $22,745,000 | +57.3% | 1,637,507 | +115.6% | 0.00% | – |
| Q4 2021 | $14,464,000 | -14.4% | 759,672 | +1.4% | 0.00% | – |
| Q3 2021 | $16,890,000 | – | 748,980 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,884,492 | $75,256,396 | 12.94% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $93,331 | 11.66% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $521,565,816 | 11.63% |
| COMMODORE CAPITAL LP | 1,075,000 | $28,046,750 | 4.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 281,533 | $7,345,196 | 3.03% |
| Perceptive Advisors | 2,300,048 | $60,008,252 | 1.77% |
| Boxer Capital, LLC | 1,210,192 | $31,574 | 1.55% |
| Avoro Capital Advisors LLC | 1,888,888 | $49,281,088 | 0.73% |
| Soleus Capital Management, L.P. | 236,900 | $6,180,721 | 0.64% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,402,525 | $36,591,877 | 0.51% |